Fasken advised Ergoresearch Ltd., a Quebec-based company headquartered in Laval that designs and manufactures cutting edge technologies for the orthopedic industry, in a going private transaction. Pursuant to the amalgamation,, all of the outstanding shares of Ergoresearch have been acquired by a corporation controlled by Sylvain Boucher and Danielle Boucher, in partnership with Walter Capital Partners Inc., for a cash consideration of $0.30 per share. The transaction was approved unanimously by Ergoresearch’s board of directors, following the favourable recommendation of the special committee of the Board
As a result of the transaction, the common shares of Ergoresearch have been de-listed from the TSX Venture Exchange.
The Fasken team that advised Ergoresearch on this transaction was led by Michel Boislard and included Caitlin Rose, Sébastien Bellefleur, Marie-Christine Valois, and Janie Harbec.
